Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02996331 · ClinicalTrials.gov registry record · NA

Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
2,113
Enrollment target

NCT02996331 is a NA study that has completed, run by Duke University. The registered enrollment target is 2,113 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02996331, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
2,113 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether repositioning frequency can be extended for nursing home (NH) residents who are low, moderate, and high risk for pressure ulcer (PrU) development. The investigators will also determine how changes in medical severity interact with changes in risk level and repositioning schedule to predict PrU development. This study will advance knowledge about repositioning frequency and clinically assessed PrU risk-level in relation to medical severity. Outcomes of this research will contribute to future guidelines for more precise preventive nursing practices and refinement of PrU prevention guidelines.

Interventions

  • OTHER 2 hour repositioning
  • OTHER 3 hour repositioning
  • OTHER 4 hour repositioning

Trial Details

FieldValue
Enrollment Target 2,113 participants
Start Date 2017-05-16
Est. Completion 2019-10-11
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02996331

The ClinicalTrials.gov registry entry for NCT02996331 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which 2 hour repositioning is the first listed.

NCT02996331 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02996331 about?

NCT02996331 is a clinical study titled "Preventing Pressure Ulcers With Repositioning Frequency and Precipitating Factors". The purpose of this study is to determine whether repositioning frequency can be extended for nursing home (NH) residents who are low, moderate, and high risk for pressure ulcer (PrU) development. The investigators will also determine how changes in medical severity interact with changes in risk lev...

What is the current status of trial NCT02996331?

This trial is currently completed. It is a NA study. The enrollment target is 2,113 participants. The study started on 2017-05-16. Estimated completion is 2019-10-11.

What interventions are being tested in trial NCT02996331?

The interventions under investigation include: 2 hour repositioning (OTHER), 3 hour repositioning (OTHER), 4 hour repositioning (OTHER).

Who is sponsoring clinical trial NCT02996331?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.